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Aortic coarctatlon 
Deep Hypothermic Circulatory Arrest for the Surgica~ 
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1046-66.348A 
Aortic regurgitation 
A Load Adjusted Performance Index Enhances 
Prediction of Temporal Changes in Left Ventdcular 
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Prosthesis and the Role of Leaflet Repair in the Valve 
Sparing Operation I085-131.423A 
Impact of Vasodilator Use on Adverse Events in 
Chronic Severe Aortic Regurgitation 1085-136.424A 
Increased Fibronectin Synthesis Is Stimulated by 
Autocrine Factors Secreted by Fibroblasts From 
Aortic Regurgitant Hearts 893-6.434A 
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Mediated by c-Jun/ATF-2 Complex Formation With 
cAMP Response Element in Cardiac Fibroblasts 
1085-135.424A 
Postoperative Myocardial Wall Stress in Patients With 
Chronic Aortic Insufficiency: Ross Procedure Versus 
St. Jude Mechanical Aortic Valve Prosthesis 
1180-131.430A 
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Imaging: Comparison With the Doppler Continuity 
Equation and Laser Flow Visualization 1189-49.386A 
Aortic Valve Calcium Measured by Electron Beam 
Computed Tomography: A Potential New Measure of 
Aortic Stenosis Severity 893-5.434A 
Can Instantaneous Changes in Aortic Valve Area 
During Ejection Predict Valve Area Response to 
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Exercise Testing Predicts Symptom Onset in Aortic 
Stenosis: A Prospective Study of 85 Patients 
1036MP-130.421A 
Influence of Coronary Artery Bypass Grafting on the 
Outcome of Aortic Valve Replacement in the 
Presence of Left Ventricular Dysfunction: The VERDI 
(Valve Replacement With Left Ventricular Dysfunction 
Italian) Surgical Study 837-5-428A 
Is Magnetic Resonance Imaging a Reliable Tool for 
Quantifying Aortic Valve Stenosis? 1140-52.368A 
Left Ventdcular Longitudinal Shortening in Patients With 
Aortic Stenosis: Relationship With Symptomatic 
Status 1036MP-124.420A 
LV Remodeling Following Aortic Valve Replacement for 
Aortic Stenosis in the Elderly 1036MP-121.419A 
Mechanisms of Mitral Regurgitation in Aortic Stenosis: 
Lack of Relationship to Aortic Stenosis Severity and 
Management Implications 1036MP- 127.421A 
Role of Osteoprotegerin i  the Pathogenesis of Calcific 
Aortic Stenosis 893-4.434A 
Should CABG Patients With Mild or Moderate Aortic 
Stenosis Undergo Concomitant Aortic Valve 
Replacement? A Decision Analysis Approach to the 
Surgical Dilemma 837-2.427A 
Strict Control of Blood Pressure May Have Benefical 
Effects on Regression of Left Ventricutar Hypertrophy 
After Aortic Valve Replacement for Pure Aortic 
Stenosis 1203-136.433A 
The Effect of Aortic Valve Replacement on Coronary 
Flow Reserve in Patients With Hemodynamically 
Significant Aortic Stenosis and Normal Coronary 
Angiogram 1211-52.391A 
The Rate of Hemodynamic Progression Is Strongly 
Predictive of Clinical Outcome Mostly in Mild and 
Moderate Aortic Stenosis 1036MP-122-419A 
Transcatheter Aortic Valvuloplasty Assisted by Right 
Ventricular Pacing 1190-98.412A 
Valvular Aortic Stenosis: Risk of Cerebral Embolism in 
Patients Undergoing Retrograde Catheterization of 
the Aortic Valve-Prospective Randomized Study 
1132-136.426A 
Aortocoronary bypass 
Comparative Outcomes of Percutaneous Coronary 
Interventions in Diabetics Versus Nondiabetics With 
Prior Coronary Artery Bypass Grafting 844-3.48A 
Emergency CABG After Failed PCI in Contemporary 
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Hypertension Patients 875-4.395A 
Strain Rate Imaging or Doppler Myocardial Imaging for 
the Detection of Regional Myocardial Ischemia 
During Stress Echocardiography: Which Method Is 
Superior? 1165MP-125.380A 
Stratification of Risk for a First Cardiovascular Event in 
the Elderly: Importance of Echocardiography 
1065-142.146A 
Systolic Intraventricular Pressure Gradients Measured 
by Color-Doppler M-Mode: A New Tool to Assess 
Ventrioular Hemodynamics 803-4.358A 
The Association of Isosorbide-5-Monitrate oan ACE 
Inhibitor Started Early After Myocardial Infarction 
Improves Left Ventricular Structure and Function 
Over Three Months: The Delapril and Remodelling in 
Acute Myocardial Infarction (DRAMI) Study 
1027-42.287A 
The Diagnostic Yield of Echocardiographic Testing in 
Pediatric Patients With Chest Pain 1167-100.411A 
The Digital Echocardiography Lab Has Arrived: Direct 
Comparison of Digital Versus Video Readings in 100 
Patients 1216-164.459A 
The Echo Stethoscope: Is It Ready for Prime Time by 
Medical Students? 1143-167.448A 
The Effect of Dobutamine Stress on Ejection and Filling 
Hemodynamics in Dilated Cardiomyopathy 
1164-65.378A 
The Optimum Hypoglycemic Therapy Can improve 
Coronary Flow Velocity Reserve in Diabetic Patients: 
Demonstration by Transthoracic Doppler 
Eohocardiography 1045-59.346A 
The Prevalence of Heart Failure in the Permanently 
Paced Population and the Utility of BNP as a 
Screening Tool 1111-t62.160A 
The Relationship Between Strain Rate Values in 
Orthogonat Directions t 187-61.384A 
The Role of Adventitia in Coronary Atherosclerosis: 
Results of Echocardiographic Imaging of the Left 
Anterior Descending Coronary Artery 834-3.246A 
The Six-Minute-Walk Test Better Reflects the 
Improvement in Valve Hemodynamics After 
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Percutaneous Mitral Valvuloplasty for Mitral Stenosis 
1155-133.429A 
Tissue Displacement imaging: Second-Generation 
Tissue Doppler With Angle Correction and 
Quantitative Color-Coded Wall Displacement for 
Assessment of Regional Ventricular Function 
803-3.358A 
Transthoracic Doppler Echocardiography Versus 
Exercise 201-TI Single Photon Emission Computed 
Tomography in Physiological Assessment of 
Intermediate Coronary Stenosis 1211-51.390A 
Transthoracic Doppler Harmonic Echocardiography 
Detects Microvascular Dysfunction in Patients with 
Arterial Hypertension 891-6,276A 
Transthorecic Echocardiographic Measurement of 
Coronary Flow Reserve in the Right Coronary Artery: 
Comparison With Invasive Data 1045-61.346A 
Transthorecic Echocardiography Using Native Tissue 
Harmonic Imaging: Diagnostic Alternative to 
Transesophageal Echocardiography in Patients With 
Suspected Infective Endocarditis 1132-132.426A 
Utility of Natriuretic Peptides for Detecting Left 
Ventricular Hypertrophy and Dysfunction: The 
Framingham Study 895-4.201A 
Validation of Real-Time Three-Dimensional 
Echocardiography for Quantifying Right Ventricular 
Volume: An In Vitro Study in Static and Pulsatile RV 
Models 1044-58-345A 
Validation of TEl index in the Estimation of Cardiac 
Function: An Experimental Study 835-1.372A 
Value of Novel Ultrasonic Radio Frequency Signals 
Analysis in Assessing Effect of Aldosterone Inhibition 
on Cardiac Structural Abnormality 1118-52.364A 
Which Echo/Doppler Index Is Most Predictive of 
Adverse Outcome in Patients With Severe Heart 
Failure Referred for Transplantation? 1187-59.383A 
Ejection fraction 
A Load Adjusted Performance index Enhances 
Prediction of Temporal Changes in Left Ventricular 
Ejection Fraction Among Asymptomatic Patients With 
Chronic Nonischemic Aortic Regurgitation and 
Initially Normal Resting Function 893-1-433A 
Association of Angiotensin Converting Enzyme Gene 
Polymorphism With Tachycardia Cardiomyopathy 
1188-103.114A 
Cardiovascular Mortality of Patients With a Restrictive 
Filling of the Mitral Inflow and Preserved Systolic 
Function 835-5.373A 
Comparison of the Effects of Lisinopril and a Pmlyl 
4-Hydmxylase Inhibitor (FG041) on Left Ventricular 
Function After Acute Myocardial Infarction 
1204-145.193A 
Does ECG-Gated SPECT Provide Accurate 
Measurement of Left Ventricular Ejection Fraction 
and Volumes? A Meta-Analysis 1213-65.394A 
Does Gated 18-F-Fluoredeoxyglucose Positron 
Emission Tomography Accurately Define Cardiac 
Function and Better Characterize Myocardial Tissue? 
1213-49.393A 
Effect of B-Blocker Therapy for T-Wave Alternans and 
Cardiac Sympathetic Function in Patients With 
Nonischemic Heart Disease 1093-110.95A 
Effect of Left Ventricular Function on Long-Term Left 
Ventricular Pacing and Sensing Threshold 
1162-103.111A 
Hemodynamic Assessment of Septic Mice Deficient in 
Inducible Nitric Oxide Synthase Demonstrates 
Improved Myocardial Performance 1181-145.186A 
Left Ventricular Longitudinal Shortening in Patients With 
Aortic Stanosis: Relationship With Symptomatic 
Status 1036MP-124.420A 
Maintenance of Sinus Rhythm After Cardioversion Is 
Dependent on immediate Improvement of Left 
Ventricular Systolic and Diastolic Function 
1163-67.377A 
Mitral Annular Motion Assessed by Real-Time 
Three-Dimensional Echocardiography Is Related to 
Left Ventricular Function Defined by Magnetic 
Resonance Imaging 1044-52.344A 
N-Terminal Pro Brain Natriuretic Peptide (NT-proBNP) 
Predicts Left Ventricular Function and Mortality in 
Hemodialysis Patients but Not Cardiac Death: A 
Two-Year Outcome Study 1201-81,268A 
Racial Paradox in Congestive Heart Failure Survival in 
Patients With Normal Left Ventricular Ejection 
Fraction 869-2.19fA 
Rapid Evaluation of Right Ventricular Volume and Mass 
Without Breath-Holding Using Real-Time Interactive 
Cardiac Magnetic Resonance Imaging System 
1140-67.368A 
Revascularization in Severe Ventricular Dysfunction: A 
Comparison of Bypass Surgery and Percutaneous 
Intervention 1182-158.187A 
Reverse Remodeling Following Long-Term Carvedilol 
Therapy Is Associated With Improvement in Survival: 
The Stanford Carvedilol Echocardiographic Registry 
1062MP-121.f4fA 
KE~. Abstract Title, Session-abstract numbePpage number 
JACC March 6, 2002 
Ventricular Interaction Impacts Left Ventdcular Systolic 
Function in Heart Failure 1014-154.129A 
Electric countershock 
Incidence and Causes of Commited Shocks in 
Noncommited Implantable Defibrillators 
1092-114.93A 
Regional Gap Junction Inhibition Increases 
Defibrillation Energy Requirements 1209-109.121A 
Regional Isoproterenol Increases Defibrillation Energy 
Requirements 1209-110.121A 
Test of a New Reduced-Current Biphasic Waveform in 
Transthoracic Defibdllation of Canines 
1209-106.120A 
Verapemil Around Electrical Cardioversion of Persistent 
Atrial Fibrillation: Results From the VeRAF Study 
1090MP-130.91A 
Electrocardiography 
80-Lead Body Map Detects Acute ST Elevation 
Myocardial Infarction Missed by Standard 12-Leed 
Electrocardiography 1192-35-332A 
A Vector-Based 5 Electrode 12-Lead ECG (EASI®) Is 
Equivalent o the Conventional 12-Lead ECG for 
Diagnosis of Myocardial Ischemia 1210-118.122A 
Abnormal Spatial Dispersion of QRS Duration Predicts 
Mortality in Patients With Mild to Moderate Chronic 
Heart Failure 1068-113.88A 
Assessment of Arrhythmogenic Potential in Brugada 
Syndrome: Comparison Between Two Configurations 
of ST Segment Elevation 1019-114.80A 
Association Between Ischemic Electrocardiographic 
Abnormalities and C-Reactive Protein in a General 
Population 842-4.248A 
Characteristics and Outcome of Patients With ST 
Elevation Versus Non-ST Elevation Myocardial 
Infarction: Results of the MONICA Augsburg 
Myocardial Infarction Registry 1985-1995 
1101-33.303A 
Detecting Myocardial Ischemia From Four Bipolar 
Leads Reconstructed From the Unipoles That Are 
Potentially Available in Implanted Devices 
851-2-320A 
Differential 12 Lead Electrocardiographic 
Manifestations of Arthythmogenic Right Ventdcular 
Dysplasia Versus Right Ventdcular Outflow Tract 
Vent dcular Tachycardias 1114-114.98A 
Do All Q Waves After Coronary Bypass Surgery Impact 
Six-month Prognosis? 1194-42.335A 
Effects of Oral Flecainide and Amiodarons on Atdal 
Fibdllatory Frequency in Persistent Human Atrial 
Fibrillation 829-4.103A 
Electrocardiogram in Hypertrophic Cardiomyopathy 
Revisited: Does ECG Pattern Predict Phenotypic 
Expression and Left Ventdcular Hypertrophy or 
Sudden Death? 1112-153.161A 
Electrocardiographic Appearance of Old Myocardial 
Infarction in Paced Patients 1210-117.122A 
Electrocardiographic Findings in Patients With 
Arrhythmogenic Right Ventdcular Cardiomyopathy 
and Idiopathic Ventdcular Tachycardia: Potential Role 
for Risk Stratification? 1038-149.136A 
Electrocardiographic Markers of Cardiac Hypertrophy 
Show Greater Heritability Than Echocardiographic 
Left Ventdcular Mass: A Family Study 1108-92.237A 
Electrocardiographic Poor R Wave Progression: 
Analysis of Multiple Criteria Reveals Little Utility 
1210-103.121A 
Gender Differences in the Electrocardiogram and Fat 
Free Mass: The Strong Heart Study 819-4.97A 
Intraatdal Conduction Abnormalities in Patients With 
Brugeda-Type ECG Estimated by P Wave Triggered 
Signal-Averaged ECG 1161-116.110A 
Is the QRS Morphology of a Clinical Ventdcular 
Tachycardia Required to Guide Catheter Ablation? 
1210-119.122A 
tschemic ECG Response During Dipyddamole Stress 
Testing Is a Powerful Predictor of Severe Coronary 
Artery Disease in Patients With Claudication Due to 
PeripheratArtedal Disease 1129-96.242A 
Left Bundle Branch Block and Quantitative Regional 
Myocardial Blood Flow Patterns in Humans - 
Adenosine vs. Bicycle Stress in PET 1141-60.369A 
Magnetecardiography in the Detection of Fetal 
Arrhythmias 1214-99.415A 
New Persistent and Rate-Related Left Bundle Branch 
Block in 116 Apparently Healthy Males: Correlation 
With Coronary Angiography and Cardiac Risk 
Factors 1210-120.122A 
Predictive Value of 60-Minute ST Segment Resolution 
in Electrocardiogram After Lytic Therapy in Patients 
With Acute Myocardial Infarction: Results From the 
GUSTO V-RESTART Study 1100-39.301A 
Predictors of Early Permanent Pacemaker Implantation 
Following Aortic Valve Replacement 1203-133.433A 
Prognostic Importance of a Wide QRS Complex in 
Asymptomatic Patients with Depressed Left 
Ventricular Function in Predicting Mortality 
1205-138.193A 
Prognostic Significance of Ischemic 
Electrocardiographic Changes Dudng Adenosine 
Infusion in Patients With Normal Myocardial 
Perfusion Imaging 817-1.381A 
Prognostic Va!ua of Normal Stress Echocardiography in 
the Presence of a Markedly Positive Stress 
Electrocardiogram 1070-66.351A 
Prolonged PR Interval Is Associated With Increased 
Risk of Atdal Fibdllation: The Fremingham Heart 
Study 884-6.125A 
QRS Duration Is a Strong Predictor of Mortality in 
Patients Undergoing Electrophysiologic Studies 
1068-115.88A 
QRS Duration on the Surface12 Lead ECG is an 
Independent Predictor of Mortality: A Study of 4.033 
Patients With Known or Suspected Coronary Artery 
Disease 1068-114.88A 
QT Dispersion Is Not Associated With Left Ventricular 
Function in Eldedy Patients With Symptomatic Heart 
Failure: ELITE II Substudy 1016-141.132A 
Radty of Circumflex Culprits in ST-Elevation MI is Due 
to Relative ECG Silence 1100-45.302A 
Regression of Echocardiographic Left Ventdcular 
Hypertrophy in Relation to Resolution Versus 
Persistence of Electrocardiographic Strain After One 
Year of Antihypertensive Therapy: The LIFE Study 
1108-69.236A 
Temporal Complexity of Repoladzation and Mortality in 
Patients With Implantabla Cardioverter-Defibdllators 
1068-116.88A 
The Clinical Value of Using Specific Electrocardiogram 
Cdteria in Predicting the Site of the Occluded Artery 
in Acute Myocardial Infarct Patients Undergoing 
Emergency Percutaneous Coronary Intervention 
1210-104.121A 
Validation of a Simple Electrocardiographic Cdtedon for 
Early Risk Assessment in Patients With Non-ST 
Segment Elevation Acute Myocardial Infarction 
1145-28.316A 
Value of Immediate Postoperative Electrocardiogram to 
Readjust Risk Stratification of Patients Undergoing 
Major Noncardiac Surgery 884-1.124A 
Ventricular Gradient Is an Independent Risk Factor in 
Survivors of Acute Myocardial Infarction 884-3.125A 
Electron beam CT 
Age and Lipoprctein(a) Are Independent Predictors of 
Coronary but Not Aortic Arteriosclerosis on Electron 
Beam Tomography 882-6.275A 
Aortic Valve Calcium Measured by Electron Beam 
Computed Tomography: A Potential New Measure of 
Aortic Stenosis Severity 893-5.434A 
Change in Calcified Plaque Burden in Relation to 
Aggressiveness of Treatment and Baseline LDL 
Cholesterol Levels 1107°89.236A 
Comparison of Statin Versus Statin+Niacin Treatment 
in Primary Prevention: Effect on Change in Calcified 
Plaque Burden 1107-90.236A 
Coronary Calcifications in Young Patients With First, 
Unheralded Myocardial Infarction: A Risk Factor 
Matched Analysis by Electron Beam Tomography 
805-4.359A 
Determinants of the Progression of Coronary 
Calcification: A Multivadate Analysis in 250 Patients 
1166-56.381A 
Direct Comparison of Electron Beam Tomography and 
Dobutamine Stress Echocardiography for the 
Detection of Significant Coronary Artery Disease 
1166-57.382A 
Electron Beam Computed Tomography and Cardiac 
Transplant 1183-147.188A 
Electron Beam Tomography Permits to Noninvasively 
Rule Out Coronary Artery Stenoses in Patients 
Scheduled for Noncoronary Cardiac Surgery 
1096-58-357A 
Ethnicity and Calcified Atharoscterosis: Can Data on 
Coronary Calcium Be Applied Evenly Across Ethnic 
Groups? Results From the Prospective Army 
Coronary Calcium Project 805-1.359A 
Increased Severity of Coronary Atherosclerosis Among 
Asymptomatic Asian-Indians 1166-55.381A 
Maximal Lipid Lowedng Therapy Decreases Calcified 
Plaque Volume and Increases Calcified Plaque 
Density 1107-87.235A 
Novel Noninvasive Strategy for Cardiac AIIograft 
Vasculopathy Surveillance and Timing of Cardiac 
Catheterizations in Heart Transplant Recipients 
1183-150.188A 
Plasma Homocysteine and Not C-Reactive Protein 
Predicts Progression of Atherosclerosis 805-3.359A 
Risk-Adjusted Mortality by Extent of Coronary 
Calcification 827-6.447A 
Statin Therapy but Not Exercise Inhibits Rates of 
Progression of Coronary Calcification 1107-88.238A 
Sub-Clinical Atherosclerosis in Hypertensive 
Individuals: The Role of Conditional Risk Factors 
805-2.359A 
The Metabolic Score Predicts Subclinical 
Atherosclerosis Independent of Fasting Serum LDL: 
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Evidence Supporting Inclusion of the Metabolic 
Syndrome as a Component Within the NCEP ATP III 
Guidelines 1179-77.262A 
Electrophermanology 
Azimilide Inhibits Outward Potassium Currents in 
Human Atdal Myocytes 1082-75.225A 
Regional Gap Junction Inhibition Increases 
Defibrillation Energy Requirements 1209-109.121A 
Regional Isoproteranol Increases Defibrillation Energy 
Requirements 1209-110.121A 
Electrophyslology 
A Novel Index Reveals Dual Pathway Conduction 
During Atrial Fibdllation 871-1.123A 
Are Programmable Shock Vectors Required to 
Optimize Atrial Defibrillation? 1092-112.93A 
Catheter Stimulation of Cardiac Parasympathetic 
Nerves in Man: A Novel Technique 1041-104.81A 
Cellular Electrophysiology Differs in Swine and Human 
Ventricles 1136-116.108A 
Characteristics of Activation Recovery Interval 
Dispersion From the Whole Chest in Normal Children 
and in Children With Prolonged QT 1093-106.94A 
Characterization of Focal Atdal Techycardia Originating 
From Pulmonary Veins in Isolated Canine Left Atdum 
Using Optical Mapping 871-2.123A 
Comparison of Adenosine-Sensitive and 
Adenosine-Resistant Accessory Pathways in 
Children 1142-98.409A 
Compensatory Electrical Remodeling in Hearts of 
Transgenic Mice That Overexpress the Ca,?.+ 
Channel Alpha 1C Subunit 1181-142.185A 
Correlation of Left Atrial Mechanical and Electdcal 
Remodeling Following Short Duration Atrial 
Fibdllation 1163-50.376A 
Delayed Electrical Activation of the Left Septum and 
Lateral Wall in Left Bundle Branch Block: Insight 
From 3-D Electroanatomical Mapping 815-4.96A 
Demonstration of the Exact Anatomical Tachycardia 
Circuit of the Typical Atrial Flutter Using Entrainment 
Mapping 1185-113.115A 
Do Changes in Local Cardiac Electrophysiology 
Influence Ventdcular Fibrillation Cycle Length? 
1091-117.92A 
Does Transmural Reentry Exist After 
Near-Defibdllation-Threshold Shocks: 
Three-Dimensional Mapping of Ventdcular 
Defibdllation 1091-103.91A 
Effect of Time and Energy on Magnetic Resonance 
Imaging of Acute Radiofrequency Ablation Lesion 
1071-68.353A 
Effects of Candesartan to Prevent Fatal Arrhythmias 
Following Acute Myocardial Ischemia and 
Reperfusion: An Elsctrophysiotogical Study Using 
Canine Hearts 
1091-120.93A 
Effects of Oral Flecainide and Amiodarone on Atrial 
Fibrillatory Frequency in Persistent Human Atrial 
Fibdllation 829-4.103A 
Efficacy of Combined Treatment With Focal Ablation 
and Pulmonary Venous Isolation for Atrial Fibrillation 
1208-115.119A 
Extended Distribution of Prolonged and Fractionatod 
Right Atrial Electrograms Predicts the Development 
of Chronic Atdal Fibrillation in Patients With Idiopathic 
ParoxysmaiAtdal Fibrillation 1185-117.116A 
Heart Rate Turbulence and Fractal Scaling Coefficient 
in Response to Premature Athal and Ventricular 
Complexes and Relationship to the Degree of 
Prematurity 819-5.97A 
Hospital Readmission After Cardioverter Defibrillator 
Implantation: Single Chamber Versus Dual Chamber 
Devices 826-2.102A 
Human Beta3-adrenoreceptors couple to the KvLQT1/ 
minK Potassium Channels via Protein Kinase A - 
Protein Kinase C Cross-talk 1041-120.82A 
Implantabla Cardiac Defibrillator Use in Patients With 
Arrhythmogenic Right Ventricular Dysplasia 
826-3.102A 
Increased Cycle Length Variability During Ventdcular 
Fibdliation: A Novel Predictor of Arrhythmia 
Recurrence 1091-104.91A 
Induction of Cardiac Nerve Sprouting and Sympathetic 
Hypednnervation by Subthreshold Electrical 
Stimulation of the Left Stellats Ganglion in Dogs 
1041-103.81A 
Kinetics of Shock Induced Transmembrane 
Poladzation: Effect of Ischemia 1209-108.120A 
Left Bundle Branch Block Reduces the Specificity of 
T-Wave Aiternans Testing 1186-108.117A 
Mechanism of Fibrillation Induction by Upper Limit of 
Vulnerability Shocks: An Optical Mapping Study in 
Isolated Swine Hearts 1160-106.108A 
Mechanisms Underlying the Reentrant Circuit of 
Ventricular Tachycardia in Isolated Canine Left 
Ventdcular Preparation Using Optical Mapping 
1160-109.109A 
KEY:. Abstract Title, Session-abstract numbePpaga number 
532A SUBJECT INDEX 
Multisite or Septal Pacing for Arrhythmia Suppression 
in an Experimental Model of Paroxysmal Atdal 
Fibrillation? 1043-111A.85A 
Prevalence of Self-Reported Syncope: An 
Epidemiologic Study From Olmstad County, MN 
1185-105.114A 
Procainamide Challenge Significantly Increases the 
Yield of Electrophysiologic Testing for Risk 
Assessment Without Loss of Positive Predictive 
Value 1186-111.117A 
Procedure Time and Success Rate for the Placement of 
a Coronary Venous Lead Designed for Left 
Ventricular Pacing 1017-106.77A 
Pulmonary Vein Diameter is Increased in Patients With 
Paroxysmal Atrial Fibrillation Compared to 
Age-Matched Controls 1185-118.116A 
Pulmonary Vein Isolation During Minimally Invasive 
Mitral Valve Surgery: One-Year Follow-Up 
1208-116,120A 
Purkinje Network Is the Origin of the Beats in 
Catecholaminergic Bidirectional Ventricular 
Tachycardia nd in the Initiating Beat of Short 
Coupling Variant of Torsade de Pointes 
1091-119.92A 
QRS Duration Is a Strong Predictor of Mortality in 
Patients Undergoing Electrophysiologic Studies 
1068-115.88A 
Remote Control of a Magnetic Electrophysiology 
Catheter Allows Precise Intracardiac Navigation and 
Eliminates Radiation Exposure to the Operator 
868-3.118A 
SIN-l, a Nitric Oxide Synthase Donor, Reduces 
Isoproterenol-Stimulated Calcium Current in Both 
Wild Type and Genetically Engineered Mouse Hearts: 
Findings From G Protein Subunit Gene Knockout 
Mice 1136-111,104A 
The Differences Between Posteroseptal and the Other 
Atrioventricular Accessory Pathways: The Coronary 
Sinus Morphology and the Conduction Over 
Accessory Pathways 1161-112.109A 
The Mechanism of Ventricular Arrhythmia on a Canine 
Isolated BIood-Perfused Brugada Syndrome Model 
857-3.112A 
Three-Dimensional Visualization of Electrophysiologic 
Landmarks : A Intrecardiac Echocardiography (ICE) 
Study 1069-53.348A 
Emergency care 
80-Lead Body Map Detects Acute ST Elevation 
Myocardial infarction Missed by Standard 12-Lead 
Electrocardiography 1192-35.332A 
B-Type Natriuretic Peptide Adds to Clinical Judgement 
in the Diagnosis of Heart Failure: A Bayesian 
Analysis From the BNP Multinational Study 
1061-157.140A 
Cardiovascular Manifestations of Carbon Monoxide 
Poisoning 840-6-314A 
Catheter-Based Treatment Approach for Patients With 
Acute Stroke Ineligible for Intravenous Thrombolysis 
1197-10.67A 
Comparison of Early Dobutamine Stress 
Eohocardiography, Exercise Treadmill Testing, and 
Hospital Admission for Management of Patients 
Presenting to the Emergency Department With Chest 
Pain: A Multicenter International Randomized Study 
1143-163,447A 
Defibrillation Threshold and Cardiac Function Using an 
External Biphasic Defibrillator in Pediatdc-Sized Pigs 
1003-35.282A 
Early Identification of Myocardial infarction in the 
Emergency Department by a Change in Serum 
Myoglobin 1074-37.293A 
Effective Predischarge Triage at the Emergency Room 
With Dobutamine Stress Eohocardiography and 
Cardiac Troponin T 1070-61.350A 
Head to Head Comparison of the Diagnostic Value of 
Bedside Measurement of B-Type Natduretic Peptide 
and Echocardiography in Patients With Acute 
Dyspnea 895-2.200A 
Impact of an Initial Diagnostic Test on Subsequent Risk 
Stratification for Patients With Multiple ED Visits for 
Chest Pain 1143-164.447A 
Primary Results of the BNP Multinational Study: B-Type 
Natriuretic Peptide in the Emergency Diagnosis of 
Heart Failure 895-6.201A 
The National Registry of Cardiopulmonary 
Resuscitation: A Preliminary Report of 5,030 Adult 
In-Hospital Cardiac Arrests 870-1.335A 
The Prognostic Significance of Myoglobin in the 
Emergency Department in Patients With Chest Pain 
886-6.339A 
Endocerditis 
Clinical Impact of Vegetation Size and Type of 
Organism in Patients With Infective Endocarditis: A 
Transesophageal Echocardiographic Study 
1020-51-340A 
Disease Progression in Infective Endocarditis: 
Transesophageal Echocardiographic Study 
1132-133.426A 
Do AHA Antibiotic Prophylaxis Guidelines for 
Prevention of Antibiotics Need Revision? 
847-1.174A 
Incidence of Infective Endarteritis in Adults With a 
Patent Ductus Artsdosus 1072-101.401A 
Infective Endocarditis After Mitral Valve Repair: 
Echocardiographic Characteristics and Predictors of 
Outcome 1020-52.340A 
Infective Endocarditis in Elderly Patients: Results From 
the Large Multicenter FRIEND Study ( FRench Italian 
ENDocarditis Study) 1132-134.426A 
Outcome of Cardiac Surgery in Patients With 
Paravalvular Abscess Detected by Transesophageal 
Echocardiography 1180-135.430A 
Patterns of Treatment for Native Valve Streptococus 
Viridans Endocarditis Among Cardiologists Versus 
Infectious Disease Specialists 1168-167,454A 
Racial Differences in Endocarditis Treatment and 
Outcome 1132-131.425A 
Role of Serial Transthoracic and Transesophageal 
Echocardiographic Examinations in Patients With 
Suspected Infective Endocarditis 1132-135.426A 
Transthoraoio Echocardiography Using Native Tissue 
Harmonic Imaging: Diagnostic Alternative to 
Transesophageal Echocardiography in Patients With 
Suspected Infective Endocarditis 1132-132,426A 
Endothelln 
A New Approach for Inhibition of Neointimal Lesion 
Formation by Targeting Endothelin Expression 
Through CAAT/Enhancer Binding Protein Decoy 
Oligonucleotide 807-3.228A 
Activation of the Tissue Endothelin System in Severe 
Poiyglobulia 1178-86.261A 
Activity of Endothelin-t Is Increased in the Forearm 
Resistance Vessels of Subjects With Hypertension 
1080-82.222A 
Bosentan: A Therapeutic Strategy for Severe Radial 
Artery Vasospasm 1035-135.419A 
Cellular Insights Into the Role of Endothelin-1 in the 
Cardiovascular Pathology of Twin-Twin Transfusion 
Syndrome 1214-102.415A 
Chronic Selective Endothelin A Receptor Antagonism 
Preserves Myocardial Per'fusion in Experimental 
Hypercholesterolemia 1031-83.210A 
Dynamics of Ischemia-Reperfusion I jury Evaluated by 
Real-Time Myocardial Contrast Echocardiography: 
Protective Effects of a Novel Endothelin A Antagonist 
BSF 461314 816-3.360A 
Effects of the Oral Endothelin Receptor Antagonist 
Bosentan on Echocardiographic and Doppler 
Measures in Patients With Pulmonary Arterial 
Hypertension 1081-80.224A 
Endogenous Endothelin-1 Reduces the Postischemic 
Functional Recovery of Prolonged Hypoperfused 
Myocardium via the Endothelin-A Receptor 
1169MP-122.323A 
Endothelial Function, Skin Capillary Density. and 
Plasma Endothelin Levels in Hypertensive and 
Normotensive Patients With Anginal Chest Pain and 
Normal Coronary Arteriograms 1080-88.223A 
Endothelin Antagonism With Bosentan Improves 
Myocardial Mechanics and Ventricular Remodeling in 
Rats With Chronic Heart Failure 838FO-6.171A 
Endothelin Antagonism With Bosentan, a Dual 
Receptor Blocker, Normalizes Dysragulated 
Transforming Growth Factor Beta Signaling 
Pathways in Rats With Chronic Heart Failure 
1134-157.168A 
Functional Significance of Myocyte Endothelin-1 in 
Experimental Chronic Chagasic Cardiomyopathy 
1158-150.179A 
Increased Activity of Endogenous Endothelin-1 in 
Patients With Type 2 Diabetes Mellitus 
1176-74.258A 
Inotropic Effects of Selective ET-B Receptor Stimulation 
and Its Modulation by Endocardial Endothelium, NO, 
and Prostaglandins 1178-82,260A 
Inter-Relationship of Endothelin-1 and Natriuretic 
Peptide Secretory Responses to Acute Exercise in 
Patient With Chronic Heart Failure and Healthy 
Controls 1086-153.147A 
Lysophosphatidylcholine Is a Major Contributor to the 
Synergistic Effect of Mildly Oxidized Low-Density 
Lipoprotein With Endothelin-1 on Vascular Smooth 
Muscle Cell Proliferation 1034-69.214A 
Phosphoramidan Ameliorates the Functional Sequelae 
, of Experimental Chronic Chagasic Cardiomyopathy 
1158-146.178A 
Relation of Myocardial Fibrosis to Cimulating 
Aldosterone and Endothelin in Primary and 
Secondary Human Hypertension: An Ultrasonic 
Study by Acoustic Densitometry 843FO-2.249A 
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Women: A Report From the NHLBI WISE Study 
1056-83.217A 
Cardioprotection Caused by Ischemic Preconditioning 
or by an Alpha 1-Adrenergic Receptor Agonist Is 
Blocked in Heads From Epsilon Protein Kinasa C 
Knockout Mica 1099-27.299A 
Effect of Estrogen on Angiotensin Receptors, Matrix 
Metalloproteinases, and Left Ventricular Mass in a 
Transgenic Mouse Model of Human Hypertrophic 
Cardiomyopathy 1015-140.131A 
Effect of the Angiotensinogen M235T Polymorphism on 
Human Coronary Vascular Endothelial Function 
1126-85.239A 
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Electrocardiographic Markers of Cardiac Hypertrophy 
Show Greater Heritability Than Echocardiographic 
Left Ventricular Mass: A Family Study 1108-92.237A 
Ezetimibe Significantly Reduces Low-Density 
Lipoprotein Cholesterol in Homozygous Familial 
Hypercholesterolemia 1084-92.227A 
Familial Aortic DissectioWAneurysm Associated With 
Patent Ductus Arteriosus: A New Entity? 863-2.264A 
Familial Restrictive Cardiomyopathy Caused by a 
Missense Mutation in the Desmin Gene: Possible 
Role of Apoptosis in Disease Pathogenesis 
410-5.448A 
Gene Polymorphisms of TNF-b and IL-6, but Not 
TNF-a. Are Associated With the Inflammatory 
Response in Ischemic Heart Disease 1025-35.284A 
Impact of Different Endothelial Nitric Oxide Synthase 
Gene Polymorphisms on Endothelium-Dependent 
Vasoditation and Response to Exercise Training in 
Patients With Coronary Artery Disease 
1151-73.251A 
Impaired Healing in Factor Xlll KO Mice After 
Myocardial Infarction Assessed by Magnetic 
Resonance Imaging 1099-47.300A 
Molecular Autopsy for HERG Defects in Sudden Infant 
Death Syndrome 857-1.111A 
Molecular Epidomiology of Cardiac Actin Gene 
Mutations in Dilated Cardiomyopathy 1158-147.178A 
Mutation in the Promoter Region of the Hepatic Lipase 
Gene Correlates With Dyslipidemia in Type 2 
Diabetes 1083-95.226A 
Natural History of Familial Dilated Cardiomyopathy: The 
Heart Muscle Disease Registry of Trieste 
1087-147.149A 
New Mutation in Lamin NC Gene Associated With 
Severe Dilated Cardiomyopathy 1015-138.131A 
Novel Natriuretic Peptide Receptor A Genetic Variant 
Associated With Higher Blood Pressure Values in 
Normotensive Subjects 1034-74.215A 
Ptatelet GPla (G873/873A) and GPIIbllla (leu33/33pro, 
PIA1/PIA2) Glyceprotein Receptor Polymorphisms: 
An Analysis of Functional Effects and Association 
With Risk of Premature Myocardial Infarction 
814-4-229A 
Polygenic Risk Assessment Improves Usefulness of 
Genotyping in Heart Failure Populations: Additive 
Effects of ACE and eNOS Polymorphisms 
1037-158.134A 
Specific Polymorphism Groups Within a PPARg-ABCA1 
Pathway Are Associated With Future Death or 
Myocardial infarction in Patients With 
Angiographically Documented Coronary Artery 
Disease 1098-166.440A 
Spironolactone Reverses Myooyte Disarray and 
Interestitial Fibrosis in the Cardiac Troponin T 
Transgenic Mouse Model of Hypertrophic 
Cardiomyopathy 813-1.156A 
Temporal Evolution of Molecular, Functional, and 
Structural Phenotypes in a Transgenic Rabbit Model 
of Human Hypertrophic Cardiomyopathy 
838FO-2.f70A 
The Sca/Atrial Natriuretic Peptide Gene Polymorphism 
in Relation to Nonfatal Myocardial Infarctionin 
Patients With Angiogrephically Confirmed Coronary 
Heart Disease 1025-31.283A 
The Sca/Atdal Natriuretic Peptide Gene Wariants Are 
Associated With the Extent of Coronary Artery 
Disease 1172-38.328A 
The 894G T Polymorphism in the Endothelial Nitric 
Oxide Synthase Gene Influences Risk for Acute 
Myocardial Infarction Only in Subjects With Low Risk 
for Coronary Events 1025-36.284A 
The Protective Effect of the T(-107)C Promoter 
Polymorphism of the Paraoxonase Gene in Arterial 
Thrombotic Disease 1177-87.259A 
The Relationship Between Serotonin 2A Receptor 
Gene Polymorphisms and Serotonin Induced Platelet 
Aggregation 1177-89.259A 
Transforming Growth Factor-b Regulation of 
Plasminogen Activator Inhibitor-1 Gene Expression 
at the 4G/5G Polymorphism 1007MP-129.203A 
Type and Reproducibility of Symptoms in Genotyped 
Congenital Long QT Patients 1186-110.117A 
Variants of the Lipoprotein Lipase Gene Associate With 
Altered Lipid/Lipoprotein Profiles in the Caerphilly 
Heart Disease Study 1083-69.225A 
Geographic variation (small area analysis) 
Regional Differences in Quality of Care for Heart 
Failure: The Role of Patient, Physician, and Hospital 
Characteristics 849-3.452A 
Glucose 
Abnormal Hemoglobin Alc Is Associated With an 
Increased Rate of Target Vessel Revascularization in 
Nondiabetic Patients Undergoing Percutaneous 
Coronary Revascularization 844-6.48A 
Clinical Benefits of Glucose-Insulin-Potassium infusion 
in Coronary Artery Bypass Grafting: Is Improved 
Diastolic Function the Mechanism? 804-1.298A 
Fasting Blood Glucose in the Nondiabetic Range Is a 
Continuous and Graded Risk Factor for CHD 
1059-73.221A 
Functional Effect of Glucose, Insulin, and Potassium in 
Patients With Chronic Isohemic Left Ventricular 
Dysfunction 1094-52.353A 
Glucagon-Like Peptide-1 (GLP-1) Limits Myocardial 
Stunning Following Acute Coronary Occlusion and 
Reperfusion in Conscious Canines 836-5.312A 
High Prevalence of Impaired Glucose Metabolism in 
Patients With Idiopathic Dilated Cardiomyopathy 
854-1.181A 
Insulin Resistance Is Associated With Left Ventricular 
Remodeling: The Framingham Heart Study 
1010-85.207A 
Growth factors 
A Growth Factor Mixture That Significantly Enhances 
Collateral Growth 1008-75.205A 
Angiogenic Growth Factors Expression of In-Vivo 
Human Aortic Endothelial Cells Within Gas-Plasma 
Treated Implants 1105-78.234A 
Artedogenesis on Demand in Exercising Mice 
Expressing FGF-2 Under the Control of the 
Phosphoglycerate Kinase Promoter 
1008-71.204A 
Combination of VEGF-C Gene Transfer and Treatment 
With the PDGF Receptor Kinase Inhibitor STI571 
Leads to Persistent Reduction in Neointima 
Formation in Balloon-Denunded Rabbit Aorta 
872-2.69A 
Induction of Angiogenesis by Metalloproteinase 
Derived From Venom of Indian Cobra in a Model of 
Rat Hind Limb Ischemia 1008-78.205A 
Long-Term Safety and Efficacy of Intramuscular 
Administration of C1-1023 (AdGVVEGF121.10) in 
Patients With Intermittent Cleudicetion 
t 008-77.205A 
Modulation by TGF-Betal of Oxidized-LDL-Induced 
Upregulation of P-Selectin and ICAM-1 and 
Monocyte Adhesion in Human Coronary Endothelial 
Cells 1083-70.226A 
Monocyte-lnduced Killing of Vascular Smooth Muscle 
Cells: Is M-CSF the Final Common Pathway? 
853-4.256A 
Therapeutic Angiogenesis via Selective Retroinfusion 
of FGF-2 and VEGF Into the Femoral Vein in the 
Chronic Ischemic Hindlimb 1029-19-10A 
Health education 
Deterioration of Risk Factors Is Not a Major 
Determinant of Coronary Events in Depressive 
Patients With Acute Myocardial Infarction 
1145-48.317A 
Diabetes-Relatad Knowledge Is Not Associated With 
Measures of Risk Factor Control in Patients With 
Diabetes and Acute Coronary Syndromes 
t 122A- 166.443A 
Patient Knowledge and Awareness of the Importance of 
Elevated Systolic Blood Pressure 1131-78.243A 
Health services 
A Simple Quality Improvement Program Improves 
Cardiovascular Preventive Care Offered by Medical 
Housestaff at a Large, Urban Hospital Treating a 
High-Risk Inpatient Population 1024-169.436A 
Cholesterol Screening of Adults in the US: Role of 
Socio-demographic Factors 1202-88.271A 
Clinical Trials Do Not Support Strong Association of 
Beta-Blocker Therapy With Fatigue, Depression, or 
Sexual Dysfunction 1098-165.440A 
Hospitalizations for Arrhythmias in the United States, 
1985 Through 1999: Importance of Atrial Fibrillation 
1090MP-121.89A 
Influence of Poverty on Process of Care and Outcome 
in Acute Coronary Syndromes 1024°163.435A 
International Differences in Cost, Medical Resource 
Utilization, and Clinical Event Rates in a Large 
Percutaneous Coronary Intervention Study: Results 
From the EXCITE Trial 1073-168.439A 
Is Early Hospital Discharge Following Acute Myocerdial 
Infarction Associated With Increased Mortality? 
861-1.456A 
Mobile Cardiac Catheterization Laboratories in 
Community Hospitals Improve Access to Cardiac 
Catheterization in Women and Minority Patients 
1168-164.454A 
Patient Knowledge and Awareness of the Importance of 
Elevated Systolic Blood Pressure 1131-78.243A 
Prediction of Risk in Patients With Unstable Angina and 
Non-ST Elevation Myocardial Infarction: A 
Prospective Comparison of the New ACC/AHA 
Guidelines and Physician Predicted Risk 861-4,487A 
Public Reporting and Case Selection for Percutaneous 
Coronary Interventions: An Analysis From Two Large 
Multioenter PC I Databases 1024-168-436A 
Quality Improvement Over "Rme: Hospital 
Characteristics Associated With Increased Usage of 
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Beta-Blockers After Myocardial Infarction 
849-6.453A 
Racial and Gender Differences in Refusal of Coronan/ 
Angiography 1168-163.453A 
Regional Differences in Quality of Care for Heart 
Failure: The Role of Patient, Physician, and Hospital 
Characteristics 849-3.452A 
Strategies to Improve Guideline Adherence: A 
Randomized Clinical Trial 849-5.453A 
The Kansas City Cardiomyopathy Questionnaire Is 
Sensitive to Clinical Change in Congestive Heart 
Failure 890-1.460A 
Heart block 
Steroids and Antioxidant Drugs Are Equally Effective in 
Preventing Late Extension of Rediofrequency 
Ablation Lesions: Do Multiple Mechanisms Play a 
Role in This Phenomenon? 1137-105.106A 
Heart catheterization 
A Double Blind Placebo-Controlled Randomized Trial of 
Fluvastatin After Successful Percutaneous 
Intervention in Patients With Coronary Heart Disease: 
The Lescol Intervention Prevention Study (LIPS) 
1125-8.41A 
Adenovirus-Catheter Compatibility Determines Gene 
Expression Following Delivery to Porcine 
Myocardium 1029-25.11A 
Amplatzer Fenestration Device: Application in Humans 
to Maintain Patency of Fontan Fenestration and 
Shunt Through the Atrial Septum 1190-101.412A 
Approach After Thrombolytic Therapy: Invasive Versus 
Conservative Management: Global Registry of Acute 
Coronary Events 1101-37.303A 
Balloon Angioplasty and Stant Placement Through the 
Side of a Previously Placed Intravascular Stent: A 
New Option for the Intarventionalist 820-2.404A 
Clinical Outcomes and Costs of Amplatzer 
Transcatheter Closure as Compared With Surgical 
Closure of Ostium Secundum Atrial Septal Defects 
1048-168.437A 
Cost Effectiveness of Coarctation Strategies: 
Endovascutar Stent versus Surgery 1142-102.410A 
Emergency Coronary Artery Bypass Grafting Following 
Percutaneous Coronary Interventions in the Stent Era 
806-1.28A 
Endothelial Dysfunction Following Radial Artery 
Cannulization 1128-86.239A 
Gender Differences in Extent and Severity of Coronary 
Disease in the ACC National Cardiovascular Disease 
Registry 851-6.321A 
Impact of an Initial Diagnostic Test on Subsequent Risk 
Stratification for Patients With Multiple ED Visits for 
Chest Pain 1143-164.447A 
Intermediate Follow-Up for Atrial Septal Defect Closure 
With the HELEX TM Septal Occluder Device: The FDA 
Phase I Feasibility Trial 1190-100.412A 
Intervention in Saphenous Vein Grafts: A Predictive 
Model of Mortality Based on Clinical Presentation of 
5,899 Consecutive Cases in the ACC-NCDR Registry 
1028-13.8A 
Intrecardiac Echocardiography Dudng Interventional 
Catheterization for Congenital Heart Defects 
1190-99.412A 
Is Noninvasive Evaluation of Pulmonary Vascular 
Resistance Possible? 835-3.372A 
Noninvasive Method for Quantification of 
Aortopulmonary Collateral Flow in Bi-Directional 
Glenn Shunts 1167-99.411A 
Predictors of Emergency Coronary Artery Bypass 
Grafting in Percutaneous Coronary Interventions 
1194-38.334A 
The Expected Rate of Normal Coronary Arteriograms in 
the Cardiac Laboratory 1024-167.435A 
Heart conduction system 
A Novel Lamin NC Missense Mutation in a Family With 
Autosomal Dominant Dilated Cardiomyopathy With 
Conduction Abnormalities 1038-150.136A 
Delayed Electrical Activation of the Left Septum and 
Lateral Wall in Left Bundle Branch Block: Insight 
From 3-D Electroanatomical Mapping 815-4.96A 
Does Isolated Bundle Branch Block Cause Left 
Ventricular Remodeling? 854-4.181A 
New Persistent and Rate-Related Left Bundle Branch 
Block in 116 Apparently Healthy Males: Correlation 
With Coronary Angiography and Cardiac Risk 
Factors 1210-120.122A 
Spatio-Temporal Description of the Development of the 
Mouse Cardiac Conduction System Using a cGATA-6 
Gene Enhancer Marker 1121MP-127.408A 
Upgrade to Biventdcular Pacing in Advanced Heart 
Failure Patients Previously Implanted With a 
Conventional Pacemaker for a Classical Indication: Is 
It Worth It ? 815-3.96A 
Heart defects, congenital 
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A Novel Method to Noninvasively Assess Effective Flow 
Areas for Pediatric Aortic Stenosis Using Contrast 
Echocardiography Coupled With Second Harmonic 
Imaging: Comparison With the Doppler Continuity 
Equation and Laser Flow Visualization 1189-49.386A 
Amplatzer Fenestration Device: Application in Humans 
to Maintain Patency of Fontan Fenestration and 
Shunt Through the Atrial Septum 1190-101.412A 
An Assessment of the Major Flow Features that Affect 
Energy Loss and Potential for Thrombus Formation 
Within the Modified Total Cavo-Pulmonary 
Connection: Computational and Scaled In*Vitro 
Studies 1121MP-122.407A 
Aortic Regurgitation in an Outlet Ventricular Septal 
Defect Complicated by Right Coronary Cusp 
Prolapse: Predictors of Prognosis 1047-101.400A 
Beneficial Effects of Atrial Septal Defect Percutaneous 
Closure in Asymptomatic and Mildly Symptomatic 
Adults 1072-100,401A 
Biologic Response to the HELEX TM Septal Occluder 
Implantation in the Canine Heart 1142-99.409A 
Does Subaortic Membrane Position Influence Mitral 
Valve Function? 809-5.404A 
Effect of Reverse Flow on the Fluid Dynamics of the 
Total Cavo-Pulmonary Connection: A Potential 
Cause of Progressive Heart Failure 
1121MP-121.407A 
Fetal Heterotaxy Syndrome: Spectrum of Heart 
Disease, Accuracy of Diagnosis, and Clinical 
Outcome 1214-101.415A 
Heart Failure and Ventricular Dysfunction in Patients 
With Single and/or Systemic Right Ventricles 
1014-157.130A 
Heart Transplantation in Adolescents and Adults With 
Congenital Heart Disease 1072-102.401A 
How Important Is Cardiac MRI in the Management of 
Adults With Congenital Heart Disease? 
1072-99-401A 
Hydrops Fetalis: Primary Cardiovascular Etiologies and 
Clinical Outcome in 98 Affected Pregnancies 
1214-100,415A 
Impact of Preoperative Aortic Cusp Prolapse on 
Long-Term Outcome After Surgical Closure of 
Subarterial Ventricular Septal Defect 1120-100,406A 
Intracardiac Echocardiography During Interventional 
Catheterization for Congenital Heart Defects 
1190-99,412A 
Molecular Cloning and Characterization of a Potential 
Candidate Gena for Nonsyndromic Atrioventricular 
Septal Defect on 1p31-1p21 1121MP-126,408A 
Neo-Aortic Root Dilation and Regurgitation Are 
Progressive Following the Aderial Switch Operation 
867-1.413A 
Noninvasive Method for Quantification of 
Aortopulmonary Collateral Flow in Bi-Directional 
Glenn Shunts 1167-99.411A 
Prospective Echo Diagnosis and Surgical Repair of 
Anomalous Origin of a Coronary Artery From the 
Opposite Sinus With an Interarterial Course 
1167-96.410A 
Quantifying Pulmonary Regurgitation as the Difference 
Between RV and LV Stroke Volumes Using 
Real-Time Three-Dimensional Echocardiography: 
Studies in a Chronic Animal Model 809-2.403A 
Quantitative Angiographic Assessment of Pulmonary 
Blood Flow in Children With Congenital Heart Defects 
1190-102.412A 
Shortened Outflow Tract Leads to Altered Cardiac 
Looping After Neural Crest Ablation 
1121MP-128.408A 
Should We Use 2-D Echo to Assess RV Form and 
Function in Adults With Repaired Tetralogy of Fallot? 
1072-97.400A 
Subjects With Surgically Treated Complex Congenital 
Heart Disease Report Health Related Quality of Life 
Equal to Healthy Peers 867-3.413A 
Three-Dimensional Free-Breathing Pediatric 
Cardiovascular Magnetic Resonance imaging With 
Real-Time Navigator Respiratory Synchronization 
1167-102.411A 
Transesophageal Echocardiographic Guidance of 
Catheter Closure of Ventricular Septal Defects in 
Children and Adults 1069-56.349A 
Treatment of Pulmonary Arterial Hypedension 
Associated With Congenital Heart Disease With 
Intravenous Epoprostenol: Impact of Therapy on 
Timing of Transplantation 1097-97,402A 
Ultrasonic Myocardial Tissue Characterization in 
Normal and Abnormal Right Ventricle 1023-98.398A 
Validation of Real-Time Three-Dimensional 
Echocardiography for Quantifying Right Ventricular 
Volume: An In Vitro Study in Static and Pulsatile RV 
Models 1044-58.345A 
Video-Assisted Ligation of Patent Ductus Arteriosus: 
Results of Multiple Ligation Technique, Need for 
Transesophageal Echocardiography, and 
Appropriateness of Same-Day Hospital Discharge 
1120-97.405A 
Heart defects, echocardiography 
Aortic Regurgitation in an Outlet Ventricular Septal 
Defect Complicated by Right Coronary Cusp 
Prolapse: Predictors of Prognosis 1047-101-400A 
Quantifying Pulmonary Regurgitation as the Difference 
Between RV and LV Stroke Volumes Using 
ReaFTime Three-Dimensional Echocardiography: 
Studies in a Chronic Animal Model 809-2.403A 
Ultrasonic Myocardial Tissue Characterization in 
Normal and Abnormal Right Ventricle 1023-98.398A 
Heart defects, interventional 
Amplatzer Fenestration Device: Application in Humans 
to Maintain Patency of Fontan Fenestration and 
Shunt Through the Atrial Septum 1190-101.412A 
Biologic Response to the HELEX TM Septal Occluder 
Implantation in the Canine Heart 1142-99.409A 
CardioSEAL Device Closure of Multiple Atrial Septal 
Defects With and Without Atrial Septal Aneurysm 
1142-100.410A 
Intermediate Follow-Up for Atrial Septal Defect Closure 
With the HELEX TM Septal Occluder Device: The FDA 
Phase I Feasibility Trial 1190-100.412A 
Magnetic Resonance Imaging Guided Deployment and 
Postinterventional Assessment of Endovascular 
Stents in the Pulmonary Position in Swine 
1071-52.352A 
Outcomes and Impact of a Nonconfluent Pulmonary 
Artery Originating From the Distal End of the Arterial 
Duct in 43 Patients 867-4.413A 
Percutaneous Closure of Patent Foramen Ovale in 
Patients With Paradoxical Embolism: Impact of 
Patent Foramen Ovale Dedicated Devices on 
Procedural Complications and Residual Shunt 
820-5-405A 
Transcatheter Aortic VaNuloplasty Assisted by Right 
Ventricular Pacing 1190-98.412A 
Transesophageal Echocardiographic Guidance of 
Catheter Closure of Ventricular Septal Defects in 
Children and Adults 1069-56.349A 
Heart failure 
~2 Adrenergic Receptor Variant Ile164: Effect on Heart 
Failure Survival and Impact of Beta Blockade 
1037-159.135A 
A Novel Efficient Percutaneous Myocardial Gena 
Delivery System 1181-143.185A 
A Rapid BNP Assay Accurately Diagnoses Left 
Ventricular Dysfunction and Heart Failure: A 
Multicenter Study 895-5.201A 
A Simple Model to Predict Left Ventricular Systolic 
Dysfunction in a Multiethnic Community 
1157-153.176A 
Abnormal Spatial Dispersion of QRS Duration Predicts 
Mortality in Patients With Mild to Moderate Chronic 
Heart Failure 1068-113.88A 
Acute Effects of Siventricular Pacing on Noninvasive 
Parameters of Left Ventricular Systolic Function 
1111-160,159A 
Acute Subcutaneous BNP Administration i  Human 
Heart Failure Enhances Diastolic Function and Filling 
Pressures as Assessed by Doppler 
Echocardiography and Plasma ANP 869-5.191A 
Advanced Heart Failure Patients Unable to Reach ACE 
Inhibitor Targets: A High Risk Population Identified 
During Hospitalization 858-6,185A 
Altered Gene Expression of Matrix-Metalloproteinases 
and Tissue Inhibitors of Metalloproteinases in 
Patients Supported by Left Ventricular Assist Devices 
876-2.198A 
Altered Gene Expression Profile in Skeletal Muscle 
After Development of Chronic Heart Failure 
876-1,198A 
Anemia Is Associated With Worse Symptoms, Greater 
impairment in Functional Capacity, and a Significant 
increase in Mortality in Patients With Advanced Heart 
Failure 858-1.184A 
Antiarrhythmic Effect of Nonexcitatory Signal Delivery 
in Patients With Severe Left Ventricular Dysfunction 
1037-153.133A 
Anticytokine Therapy Alleviates Oxidative Stress and 
Attenuates Left Ventricular Remodeling in 
Experimental Heart Failure 1156-145.176A 
Are Racial Differences in the Long-Term Prognosis of 
Systolic Heart Failure independent of Differences in 
Etiology? 869-3-191A 
Assessment of the Myocardial Transcdptome in Heart 
Failure Using Redundant Cross-Species 
Oligonucleotide Arrays 1181-144.186A 
Association of Quality of Life With Improved Clinical 
Outcomes: Results From the Valsartan Heart Failure 
Trial 1134-155.167A 
B-Type Natriuretic Peptide Adds to Clinical Judgement 
in the Diagnosis of Heart Failure: A Bayesian 
Analysis From the BNP Multinational Study 
1061-157.140A 
B-Type Natriuretic Peptide in the Emergency Diagnosis 
of Diastolic Dysfunction Heart Failure 
1061-156.140A 
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B-Type Natriuretic Peptide Predicts Sudden Death in 
Patients With Chronic Heart Failure: A Selection 
Mode for ICD Implantation? 1061-155.140A 
Beta-Blocker Utilization in Heart Failure Patients: 
Experience From a Heart Failure Clinic 
1157-160-178A 
Body Composition and Prognosis in Chronic Systolic 
Heart Failure: The Obesity Paradox 869-4.191A 
Bone Loss and Prevention of Osteoporosis in 
Congestive Heart Failure 1134-146.165A 
Brain Natriuretic Peptide Levels Predict Exercise 
Capacity in Patients With Chronic Heart Failure 
856-6.183A 
Cardiac Resynchronization improves Ventricuiar 
Function and Symptoms of Congestive Heart Failure 
in the Absence of Any Mechanical Atrial Contribution 
1017-103.77A 
Cardiac Resynchronization Reverses Left Ventricular 
Remodeling and Reduces Cytokine Activation in 
Patients With Dilated Cardiomyopathy and Left 
Bundle Branch Block 1017-119.78A 
Cardiologists Care for a Distinct Clinical Subset of 
Older Patients Hospitalized With Heart Failure: 
Experience From the National Heart Failure Project 
1215-159.458A 
Carvedilol Initiation by Community Physicians in 
COHERE: Comparison With U.S. Cawedilol Trials 
and Compassionate Use Protocols 890-5.461A 
Characterization of a Novel Inositol 1,4,5-Trisphesphate 
Receptor/Calcineurin Signaling Pathway in Cardiac 
Hypedrophy: Effects of Heparin 1033-96.214A 
Chronic Resynchronization Therapy Does Not Alter Left 
Ventricular Geometry 1062MP-124.142A 
Chronic Therapy With Metopro~ol CR/XL Prevents 
Apoptosis inducing Factor and Downregulates the 
Pro-Apoptotic Protein Bak in Cardiomyocytes of Dogs 
With Heart Failure 1133-140-165A 
Clusters of Differential Gene Expression of Structural 
Proteins Between Failing and Nonfailing Heads: 
Preliminary Insights From Oligonucleotide 
Microarrays 1110-141.157A 
Combination of Dispersions of QRS Duration and QT 
Interval Improves a Predictive Value of Mortality in 
Patients With Mild to Moderate Chronic Heart Failure 
1093-111.95A 
Comparison of the Prognostic Value of Cardiac 1-123 
Metaiodobenzylguanidine Imaging and Heart Rate 
Variability in Patients With Mild 1o Moderate Chronic 
Heart Failure 1119-62.365A 
Comparison of Ventilatory Response Changes During 
Exercise Between Heart Failure and Normal 
Subjects: Implications for Exercise Testing 
1088-140.151A 
Complete Versus Incomplete Revascularization for 
Acute Myocardial Infarction With Killip Class Ill or IV 
Subsets 862-1.330A 
Coronary Endothelial Dysfunction Occurs Early in the 
Pathophysiology of Heart Failure 1086-160.148A 
Despite Improving Endothelial Function Oral Vitamin C 
Increases Phosphocreatine Depletion During 
Exercise in Patients With Chronic Heart Failure 
856-1.182A 
Detectable Troponin T Level Predicts High Mortality in 
Patients With Heart Failure Undergoing Internal 
Defibdllator Implantation 111t-159.159A 
Detection of Myocardial Infarction in Heart Failure 
Patients With Severe Left Ventricutar Systolic 
Dysfunction by Contrast Enhanced MRI 
1182-153.186A 
Determinants and Outcomes of Congestive Heart 
Failure Complicating Acute Coronary Syndromes: 
Observations From the Global Registry of Acute 
Coronary Events 802-5.154A 
Differences in Endothelial Function Between Patients 
With Ischemic and Dilated Heart Failure 
1152-93.252A 
Differential Effects of Carvedilol and Metoprolol on 
Sympathetic Regulation of Peripheral Vascular 
Resistance in Patients With Chronic Heart Failure 
1086-158.148A 
Disposition of Patients Referred for Cardiac 
Transplantation to a Tertiary Specialized Heart 
Failure Center in Contemporary Clinical Practice 
1064-147.145A 
Do Heart Failure Patients With Right Bundle Branch 
Block Benefit From Cardiac Resynchronization 
Therapy? Analysis of the MIRACLE Study 
815-2.96A 
Down-Regulation of Sodium Current in Heart Failure: 
Rescue by Beta-Blockers 1133-138.164A 
Dynamic Expressions of eNOS, iNOS, and TNF-a in 
Canine Myocardium in Response to Pacing*induced 
Dilated Cardiomyopathy 1110-t44.158A 
Early Detection of Regional Myocardial Dysfunction by 
Strain Doppler Echocardiography in Patients With 
Primary Amyloidosis 1134-160.168A 
Early Microvascular Reflow Status After Infarct 
Reperfusion Determines Outcome of Postinfarction 
Remodeling Independent of Myocardial Salvage 
1099-32.300A 
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Echocardiographic Predictors of Functional Class 
Changes During Cardiac Resynchronization Therapy: 
Results From the MIRACLE Tdal 1138-107.107A 
Effect of Left Ventricular Function on Loog-Term Left 
Ventdcular Pacing and Sensing Threshold 
1162-103.111A 
Effect of Reverse Flow on the Fluid Dynamics of the 
Total Cavo-Pulmonary Connection: A Potential 
Cause of Progressive Heart Failure 
1121MP-121.407A 
Effect of Valsartan on Morbidity and Mortality in Heart 
Failure Patients With a History of Hypartension: 
Results From the Valsadan Heart Failure Trial 
843FO-5.249A 
Effect of Valsartan on Time-Adjusted and 
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Heart Failure Trial 1134-159.168A 
Elaboration and Validation of a Prognostic 
Classification for Severe Chronic Heart Failure: Data 
From EPICAL and RALES Studies 802-1.153A 
Elevated Serum Creatinine and Increased Mortality in 
Women and Elderly Heart Failure Patients 
1098-170-441A 
End-Systolic Left Ventdcular Diameter _ 45 mm in 
Mitral Regurgitation Is an Insensitive Marker of Left 
Ventdcular Dysfunction and a Poor Predictor of 
Postoperative Outcome 1012-136.418A 
Endogenous Ouabain-Like Factor Predicts Progression 
Toward Heart Failure in Patients With Idiopathic 
Ditated Cardiomyopathy 1134-149.166A 
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Therapy? Analysis of the MIRACLE Study 
815-2.96A 
Dobutamine Stress Echocardiography Unmasks Global 
Left Ventdcular Dysfunction in Children With "Normal' 
Coronary Artedes Following Kawssaki Disease 
1070-65.351 A
Does Isolated Bundle Branch Block Cause Left 
Ventdcular Remodeling? 854-4.181A 
Does Off Pump Coronary Artery Bypass Graft Surgery 
Reduce Post-Operative Right Ventdcutar 
Dysfunction? 1147-43.320A 
Effects of the Creation of Arteriovenous Shunt for 
Hemodialysis on Cardiac Function and Natduretic 
Psptide Levels in Chronic Renal Failure 
1061-160,141A 
Elevated Pre-Operative Ventricular Diastolic Relaxation 
indices Correlate With Poor Outcome in Fontan 
Patients 567-5.414A 
End-Systolic Left Vantdcular Diameter _ 45 mm in 
Mitral Regurgitation Is an Insensitive Marker of Left 
Vantdcular Dysfunction and a Poor Predictor of 
Postoperative Outcome 1012-136.418A 
Evaluation of the Accuracy of a New Semiautomatic 
3-D Program (PMAP) by Quantifying Right 
Vantdcular Volume Using Real-Time 3-D Imaging: 
Studies in an In Vitro Model Duplicating Human RV 
Anatomy 1121MP-125.408A 
Fast Interactive Visualization of Human Heart in 3-D 
Space Using Real-Time Three-Dimensional 
Echocardiogrephic (RT3DE) Dataset on 
Commercially Available Low Cost Computer 
1044-53.344A 
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Left Atdai Structural and Functional Parameters 
1014-155.130A 
Gated Rubidium-82 Cardiac PET Imaging: Evaluation 
of Left VentricularWall Motion 1213-50.393A 
Gender But Not Age Affects Cardiovascular 
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Subjects 20-93 Years Old 1040-141.138A 
GeometH of Tricuspid Annulus Determined by 
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With Intact Leaflets 106g-55.34gA 
Glucocorticoids Reduce Troponin I Degradation in a 
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874-4.416A 
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t014-157.130A 
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1072-99.401 A
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Autoimmune Myocarditis 1038-152.137A 
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Left Atrial Enlargement Is a Key Indicator of Exercise 
Intolerance 1159-140.180A 
Left Vantricuiar Longitudinal Shortening in Patients With 
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1182-t56.18?A 
Selegiline Attenuates Myocyte Apoptosis by Modulation 
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Deformation Be Measured to Characterize Changes 
in Myocardial Deformation Induced by Alterations in 
Inotropic States and Heart Rate? 1165MP-128.380A 
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803-3.358A 
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Banding in Mice 894-4-396A 
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Valve Function and Anatomy 1012-132.417A 
Endothelin Antagonism With Bosentan Improves 
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Excessive Tumour Necrosis Factor Activation 
Post-Infarction Contributes to the Early Susceptibility 
to Myocardial Rupture: Evidence From TNF-/- 
Transgenic Knockout Models 886-2.338A 
Grafting of Three-dimensional Collagen Type 1 Scaffold 
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and Improves Cardiac Function 1192-34.332A 
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Outcome of the Remodeling Process 838FO-5.171A 
Increased Collagen Degradation Predicts Early 
Ventricular Remodelling Following Acute Myocardial 
Infarction 1170-34.325A 
Insulin Resistance Is Associated With Left Ventricular 
Remodeling: The Framingham Heart Study 
1010-85.207A 
Left Ventricular Filling and Remodeling After Myocardial 
Infarction: Results From the GISSI-3 Echo Substudy 
1074-31.292A 
Matrix Matalloproteinase Inhibition Attenuates 
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1001-28.278A 
Passive Ventricular Restraint With Nitinol Mesh 
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Infarction 1147-38.319A 
Reverse Mechanical Remodeling by Biventricular 
Pacing in Congestive Heart Failure: One-Year 
Results From Patients in Atrial Fibrillation in the 
MUSTIC (MUItisite STimulation in Cardiomyopathy) 
Study 878-3.124A 
Reverse Mechanical Remodeling by Biventricular 
Pacing in Congestive Heart Failure: One-Year 
Results From Patients in Sinus Rhythm in the 
MUSTIC (MUItisite STimulation In Cerdiomyopathy) 
Study 815-1-95A 
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Acute Myocardial Infarction (DRAMI) Study 
I027-42.287A 
Utility of Natriuratic Peptides for Detecting Left 
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Framingham Study 895-4.201A 
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Changes in R-R Intervals During Vsntricular 
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Different Characteristics of T Wave Aitemans Between 
Polymorphic Ventricuiar Tachycardia nd 
Monomorphic Ventdcular Tachycardia 1093-109.95A 
Differential 12 Lead Electrocardiographic 
Manifestations of Arrhythmogenic Right Vantricular 
Dysplasia Versus Right Ventricular Outflow Tract 
Ventricular Tachycardias 1114-114.98A 
Epicardial Ablation of Ventricular Tachycardia: Location 
of Successful Ablation Site and Long-Term Follow-Up 
1114-112.98A 
Epicerdial Rediofrequency Ablation of Ventricular 
Myocardium: Mechanisms of Lesion Formation and 
Damage to Adjacent Structures 1114-111.98A 
Impiantabia Defibrillator Events in Patients With 
Hypertrophic Cardiomyopethy: Low Incidence of 
Ventricular and High Incidence of Supraventricular 
Events During Intermediate Term Follow-Up 
826-6.102A 
Incidence and Causes of Commitad Shocks in 
Noncommitsd Impiantabts Defibrillators 
1092-114-93A 
Increased Cycle Length Variability During Ventricular 
Fibrillation: A Novel Predictor of Arrhythmia 
Recurrence 1091-104.91A 
Is Catheter Ablation of Hemodynamically Unstable 
Ventricular Tachycardia Feasible Using Noncontact 
Mapping? 1114-115-98A 
Is the QRS Morphology of a Clinical Ventricular 
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1210-119.122A 
Left Bundle Branch Block Reduces the Specificity of 
T-Wave Altamens Testing 1186-108-117A 
Mechanisms Underlying the Reentrant Circuit of 
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1160-109.109A 
Myocardial Contrast Echocardiography With Tdggered 
Ultrasound Does Not Cause Ventricutar Premature 
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Performance of the Electrogram Vector Timing and 
Correlation Algorithm for Discrimination of Vsntricuiar 
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Procainamide Challenge Significantly Increases the 
Yield of Electrophysiologic Testing for Risk 
Assessment Without Loss of Positive Predictive 
Value 1186-111.117A 
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Purkinje Network Is the Origin of the Beats in 
Catecholaminergic Bidirectional Ventricuiar 
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1091-119.92A 
Rediofraquency Catheter Ablation of Ventricuiar 
Tachycerdie Using a Virtual Dynamic 3-D Endocardial 
Mapping System Based on Sonomicromatry 
1114-116.99A 
The Role of Isoproterenol During Electrophysiologic 
Evaluation of Patients With Nonsustained Ventdcular 
Tachycardia 1186-109.117A 
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Adenovirus-Catheter Compatibility Determines Gene 
Expression Following Delivery to Porcine 
Myocardium 1029-25.11A 
Atazanavir Plus Saquinevir Once Daily: Favorable 
Effects on Lipid Profiles in Patients Failing Prior 
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1084-94.227A 
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Investigation of Alternative Pathways 814-5.230A 
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Previous Cytomegaiovirus Infection and the Risk of 
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Accessory Pathways 1161-112.109A 
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